Medindia
Medindia LOGIN REGISTER
Advertisement

Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco

Tuesday, January 6, 2009 General News
Advertisement
SAN CARLOS, Calif., Jan. 5 Nektar Therapeutics'(Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, isscheduled to present at the upcoming 27th Annual J.P. Morgan HealthcareConference in San Francisco at the Westin St. Francis Hotel on Tuesday,January 13, 2009 at 10:00 a.m. Pacific time (1:00 p.m. Eastern time).
Advertisement

The presentation will be accessible via a Webcast through a link posted onthe Investor Relations, Events Calendar section of the Nektar website:http://www.nektar.com. This Webcast will be available for replay untilFebruary 15, 2009.
Advertisement

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing noveltherapeutics based on its advanced polymer conjugate technology platforms.Nektar's technology and drug development expertise have enabled nine approvedproducts for partners, which include leading biopharmaceutical companies.Nektar is also developing a robust pipeline of its own high-value therapeuticsthat addresses unmet medical needs by leveraging and expanding its technologyplatforms to improve and enable molecules. For more information on NektarTherapeutics, please visit http://www.nektar.com.Nektar Contacts: Jennifer Ruddock Nektar Therapeutics 650-631-4954 [email protected] Susan Noonan The SAN Group 212-966-3650 [email protected]

SOURCE Nektar Therapeutics
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close